Global /Canada /Healthcare /Drug Manufacturers - Specialty & Generic /CPTR

Captor Capital Corp.

CPTR

• CSE: CPTR • Delayed

0.2650CAD -8.6%

0.1907 USD

As of 5 June 2026, Captor Capital Corp. has a market cap of $577.01K USD, ranking #48928 globally and #2787 in Canada. It ranks #4346 in the Healthcare sector, and #356 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

48928

Country Rank

2787

Sector Rank

4346

Industry Rank

356

Key Stats

Market Cap

$577.01KUSD

801.99K CAD

Enterprise Value

-$8.39MUSD

-11.66M CAD

Revenue (TTM)

-$805.58KUSD

-1.12M CAD

Net Income (TTM)

-$17.36MUSD

-24.13M CAD

PS Ratio

-0.7

PB Ratio

0.1

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

John Zorbas open_in_new

Employees

Founded

2003

Website

captorcapital.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-8.6%	-4.3%	-4.3%	-1.9%	-45%	10%	-70%	-96%	-96%

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	CPTR Captor Capital Corp ISIN: CA14075H3018 Shares Out.: Shares Outstanding: 3.487M¹ Shares Float: 3.427M² TV: TradingView: CSE: CPTR SA: Stock Analysis: CSE: CPTR YF: Yahoo Finance: CPTR.CN GF: Google Finance: CNSX: CPTR BA: Barron's: CPTR MS: Morningstar: XCNQ: CPTR	0.2650 CAD	TV: TradingView: CSE: CPTR SA: Stock Analysis: CSE: CPTR YF: Yahoo Finance: CPTR.CN GF: Google Finance: CNSX: CPTR BA: Barron's: CPTR MS: Morningstar: XCNQ: CPTR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Captor Capital Corp.

Captor Capital Corp. engages in the retail sale of cannabis products in the United States. The company also engages in investment and merchant banking activities. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Canada)

Name	Market Cap (USD) diff.	PE	Country
Bausch Health Companies Inc. TSX: BHC	$2.08B 2.9B CAD 361K%	13.5	Canada
Jamieson Wellness Inc. TSX: JWEL	$1.0B 1.39B CAD 174K%	23.0	Canada
Cronos Group Inc. TSX: CRON	$987.23M 1.37B CAD 171K%	-	Canada
Cipher Pharmaceuticals Inc. TSX: CPH	$333.94M 464.15M CAD 58K%	12.7	Canada
Cannara Biotech Inc. TSXV: LOVE	$126.51M 175.83M CAD 22K%	14.9	Canada
Noveris Health Sciences Inc. CSE: NVRS	$84.25M 117.1M CAD 15K%	1.1	Canada

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 7M%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 5M%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 3M%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 2M%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 2M%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 2M%	80.6	China

chevron_leftBack